Related Experiment Video

Updated: Jun 28, 2026

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats
07:56

Transient Middle Cerebral Artery Occlusion Model of Neonatal Stroke in P10 Rats

Published on: April 21, 2017

Pediatric and newborn stroke

Sharon Goodman1, Steven Pavlakis

  • 1Steven Pavlakis, MD Maimonides Infants and Children's Hospital, 977 48th Street, Brooklyn, NY 11219, USA. spavlakis@maimoindesmed.org.

Current Treatment Options in Neurology
|November 8, 2008
PubMed

Insights

Pediatric stroke, more often ischemic than hemorrhagic, presents uniquely in children. Understanding causes and identifying high-risk groups are crucial for developing effective treatments and prevention strategies.

Area of Science:

  • Pediatric Neurology
  • Vascular Neurology
  • Neonatal Medicine

Background:

  • Arterial ischemic stroke is more common than hemorrhage in children.
  • Pediatric stroke presentation is complex, varying by age, type, and location, with seizures being common, especially in newborns.
  • Identified risk factors include congenital heart disease, blood disorders, infections, and vascular malformations, though etiology often remains unknown.

Purpose of the Study:

  • To summarize the current understanding of pediatric stroke, including its presentation, risk factors, and treatment.
  • To highlight the need for further research into the natural history and risk stratification of pediatric stroke.
  • To emphasize the necessity of understanding causes for developing effective prevention and treatment strategies.

Main Methods:

  • Review of existing literature and clinical consensus on pediatric stroke.
  • Analysis of known risk factors and current treatment approaches.
  • Identification of knowledge gaps and areas for future research, particularly prospective cohort studies.

Main Results:

  • Pediatric ischemic stroke presentation differs significantly from adults.
  • Current treatments are largely based on consensus, lacking robust evidence from large studies.
  • Effective primary prevention is limited, except for sickle cell disease, while aspirin is commonly used for secondary prevention.

Conclusions:

  • Further prospective studies are essential to elucidate the natural history of pediatric stroke.
  • Identifying at-risk populations is critical for developing targeted interventions.
  • Understanding the underlying causes of pediatric stroke is paramount for advancing treatment and prevention strategies.

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia06:01

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

Related Concept Videos

Stroke: Introduction and Types01:29

Stroke: Introduction and Types

A stroke is an acute neurological event caused by the sudden disruption of cerebral blood flow, leading to rapid loss of neuronal function. Neurons depend on continuous oxygen and glucose supply, so even brief interruptions can cause irreversible injury within minutes. Strokes are classified into ischemic and hemorrhagic types.Ischemic StrokeIschemic strokes are most common and occur due to arterial occlusion, depriving brain tissue of oxygen and nutrients. This leads to energy failure, ionic...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...